Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate Cancer

NCT04635059 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT04635059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04635059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate Cancer
Lead sponsor
Medical College of Wisconsin
Phase
Phase 2
Overall status
Terminated
Start date
June 1, 2021
Completion date
October 27, 2024
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer